AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Combining Nanoparticles and Checkpoint Blockade Therapy
Detailed Technology Description
In situ immunization leadsto tumor cell death by providing antigen-presenting cells, such as dendriticcells (DCs), with tumor antigens that result in a therapeutic anticancer immuneresponse. The market size for in situ immunization is expected to reach $34 billionby 2024, which is a large increase from $34 billion expected in 2019.
Country/Region
USA
For more information, please click Here
